sexta-feira, julho 15, 2005

Activistas americanos contra o preço do tipranavir

AIDS Activists Cry Foul as Drug Companies Push Prices to Record Levels

NEW YORK, July 9
A steady onslaught of "unreasonable, unacceptable, and unjustified" increases in the price of therapies to treat HIV has caused activists in the US to accuse drugmakers of artificially inflating the market at the expense of people living with HIV/AIDS. As an example, activists point to the recent launch of the new drug Aptivus (tipranavir), a protease inhibitor developed by Boehringer-Ingelheim, which came in at the highest price ever for this class of medication-more than $13,000 per year, which does not include the cost of other medications that must be taken in combination with Aptivus.

"We are approaching the point where a year's worth of HIV medications in the US will cost anywhere from $30,000 to $50,000 a year. Every time a new medication is made available, it usually comes in at a new higher price than others in its class," stated Nelson Vergel, a member of the AIDS Treatment Activists Coalition. "The same thing happened with Reyataz, another protease inhibitor made by Bristol-Myers Squibb. It was the first once-daily medication of this kind, and the company priced it at an all-time high, with regular increases since then. It now costs almost $11,000 per year. This behavior is simply unreasonable, unacceptable, and unjustified."

Indeed, many healthcare and community groups question why there is no guidance for drug pricing based on type of medication or disease. In the US, prices charged for medications are often much higher than in other developed countries. This tends to work against patients, even those who have insurance. Howard Grossman, MD, Executive Director of the American Academy of HIV Medicine notes, "Many insurance companies have focused on the high price of drugs to treat HIV. Healthcare providers are finding their choices increasingly limited as higher-priced drugs are taken off 'preferred' lists, in some cases raising patient copays from $20 to $75 or more perprescription. Anything that prevents doctors from prescribing the properly-indicated drugs reduces our chance of controlling HIV. High prices are driving this."

But privately insured patients aren't the only ones suffering under this no-hold-barred system of pricing for life-saving and medically necessary medications. Public payer systems, such as the underfunded AIDS Drug Assistance Programs (ADAPs), provide medications for more than half of all patients with HIV/AIDS in the US. These programs must renegotiate prices regularly with drug companies, and steep increases in medication prices make it difficult to provide medication to the same number of people each year.With numbers of new infections increasing steadily and flat funding for ADAPs, medication waiting lists have developed in several states. To make matters worse, new legislation forbids government negotiation with drug companies on prices. In other words, patients receiving government assistance for healthcare may not have access to new and better medications if excluded from formulary because of expense. Even if the medications are added, they will cause patients to meet individual spending caps even more quickly and will use up allotted budgets.

"Sadly, Boehringer-Ingelheim failed to realize that the size of the potential Aptivus market is directly tied to patients' access through publicly funded programs, and they just made that market a lot smaller," said Lei Chou, Director of Mobilization at the Community HIV/AIDS Mobilization Project (CHAMP). "State Medicaid Programs will delay coverage of the drug for months, AIDS Drug Assistance Programs will have to place access restrictions or may not cover it at all. This pricing decision will put Aptivus out of reach for the majority of patients who can benefit from it." As companies continue to create a system of haves and have-nots for people living with HIV/AIDS, activists plans to redouble their efforts against price-gouging and profiteering. By working with legislators, consumer protection groups, and other advocacy groups, AIDS activists envision a future where unbridled greed does not dictate what treatments patients can afford or how public resources are spent in the effort to keep people alive.

ATAC (www.atac-usa.org) is a national coalition of AIDS activists, many living with HIV/AIDS, working together to end the AIDS epidemic by advancing research on HIV/AIDS.

ATAC
Contact: Lynda Dee
(410) 332-1170
lyndamdee@aol.com

Comments:
Muito possivelmente aquilo que se está a passar nos Estados Unidos , com o aumento dos preços dos medicamentos novos que são sempre mais caros do que os existentes vai surtir o mesmo efeito aqui na Europa ,os sistemas de saude são um pouco difrentes mas é mais do que evidente de que pelo andar da situação neste mundo global aqui não vão ser as seguradoras mas sim o proprio estado atraves dos varios organismos com competencias na area a criar cada vez mais dificuldades em deixar chegar aos doentes os medicamentos e as trapeuticas adequadas arranjando formas directas ou indirectas de fazer com que a classe medica não prescreva em consciencia mas sim de acordo com a conveniencia do ministerio da saude atraves das persões exercidas pelas administrações hospitalares ali colocadas por os governantes para que os medicos não prescrevam determinados medicamentos com um criterio de preços e não de nessecidade do doente , o maior problema é que a classe medica está em algumas situações a compactuar com esta situação fazendo os doentes pensar que eles não carecem dessas medicações , e mantendo um silencio sobre a forma de como estão a ser impedidos de exercer livremente o acto da prescrição medica arranjando inclosive pretestos de que o que era verdade á uns meses já não é assim tão importante ,querendo com isto passar um atestado de estupides aos seus doentes.
O caso do Aptivos (Tipranavir em portugal )é bem um espelho dessa situação .Á que chamar á atenção dos medicos ( pois muitos parecem ter esquecido ) que o juramento de Hipocrates não tem nada a ver com a palavra Hipocrisia , e que o silencio e a desinformação os torna coniventes dos problemas surgidos com as más prescrições que possam fazer em consequencia das persões venham elas de onde vierem desde que ponham em causa as boas praticas clinicas e o tudo fazer para salvar a vida de um ser Humano.
Nuno e Florbela Fernandes
 
Enviar um comentário

<< Home

This page is powered by Blogger. Isn't yours?

Enter your email address below to subscribe to Blog do GAT!


powered by Bloglet